FDA Compels Johnson & Johnson to Dismiss 60 million Covid-19 vaccine Doses

The U.S Food and Drug Administration (FDA), in response to the dismissal of the J&J Covid-19 vaccine, said that certain batches of doses were unsuitable for the people. The FDA is yet to disclose the exact number of doses that have been discarded.The told the media that the agency had discarded two batches of vaccine materials that were manufactured at the production site. According to reports, the two batches will account for 10 million doses.

FDA has also determined some other batches that may risk public health. Some batches that are reported not to be suitable are under review. According to the FDA statement, it will keep the public informed about the updates on the reviews.Currently, America has more than enough doses that were obtained from Pfizer and Moderna. The vaccine stocks are enough to get the whole U.S population vaccinated.

According to the latest reports, around 10 million vaccine doses of the J&J will be distributed to foreign countries from the U.S. The doses that will be donated will come with a warning. The warning states that the federal government could not guarantee that good practices were carried out while manufacturing the vaccine by the plant’s operator Emergent BioSolutions.

Before forcing the J&J to discard the vaccines, the FDA had conducted a thorough study of the quality testing results.   The federal government had planned to donate the vaccines to other countries. However, due to ongoing investigation, the distribution plans are on hold.